Equity Sector Funds Very High Risk
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Expert-managed portfolios tailored to your financial goals.
Estimation is based on the past performance
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | 5.71% | 8.21% | 0.45% | -1.13% | 4.56% | 12.59% | 24.83% | 18.68% | 15.56% | 12.3% | 16.26% |
| Category returns | 6.83% | 7.45% | 0.03% | -2.3% | 6.38% | 11.92% | 22.96% | 16.06% | 13.74% | 12.95% | N/A |
| Absolute returns | 7.76% | 9.34% | 7.31% | 6.97% | 11% | 33.5% | 103.42% | 125.38% | 110.62% | 219.01% | 5932.77% |
| Rank within category | 15 | 7 | 7 | 6 | 13 | 6 | 3 | 2 | 2 | 3 | N/A |
| Total Schemes in Category | 18 | 18 | 17 | 17 | 16 | 14 | 10 | 10 | 9 | 4 | N/A |
| Sector Funds | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | -14.02% | 2.06% | -9.89% | -0.49% | 65.84% | 20.15% | -6.02% | 38.24% | 42.22% | -3.5% | 10.1% |
| Q1 returns | -11.31% | 6.25% | -11.2% | 0.34% | -4.18% | -0.75% | -6.29% | -2.23% | 11.71% | -5.88% | -1.34% |
| Q2 returns | 1.67% | -8.92% | -2.61% | -9.1% | 27.68% | 18.2% | -9.75% | 18.64% | 4.22% | 5.21% | 11.59% |
| Q3 Returns | 5.89% | -3.27% | 9.49% | -0.3% | 22.44% | 1.15% | 8.9% | 8.96% | 17.36% | -2.85% | N/A |
| Q4 Returns | -9.95% | 9.01% | -4.84% | 9.42% | 10.71% | 1.25% | 2.05% | 9.37% | 4.09% | 0.31% | N/A |
Expense ratio: 1.9%
Inclusive of GST
Exit load
0.50% on or before 15D, Nil after 15D
| Alpha | 0.143136 |
| Beta | 0.8991 |
| Sharpe Ratio | 0.383131 |
| Sortino Ratio | 0.927733 |
| R-Squared | 0.9397 |
| Tracking Error | 1.0357 |
| Downside Risk | 14.3171 |
| Std. Deviation (Annualised) | 13.5998 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Expense Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth | 9.18% | 6.67% | -0.99% | -3.59% | 7.1% | 27.02% | 16.23% | 0% | 19.44% | 6,293.14 | 1.87 | 0.39 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW | 7.91% | 7.54% | 0.1% | -2.35% | 8.33% | 24.87% | 13.99% | 12.81% | 14.66% | 1,055.53 | 2.28 | 0.35 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW Current | 5.71% | 8.21% | 0.45% | -1.13% | 4.56% | 24.83% | 15.56% | 12.3% | 16.26% | 4,063.64 | 1.93 | 0.37 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | 6.15% | 10.25% | 3.03% | 0.11% | 9.4% | 23.81% | 14.41% | 0% | 19.42% | 2,753.72 | 1.94 | 0.34 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth | 4.7% | 6.4% | 1.22% | -1.71% | 5.37% | 22.75% | 12.57% | 0% | 18.41% | 858.87 | 2.30 | 0.33 | Very High |
| Nippon India Pharma Fund - Growth | 5.58% | 6.09% | 0.67% | -3.68% | 4.04% | 22.1% | 13.33% | 14.48% | 19.73% | 7,898.24 | 1.82 | 0.32 | Very High |
| Tata India Pharma & Healthcare Fund - Regular Plan - Growth | 6.85% | 5.21% | -3.15% | -4.34% | 2.3% | 22.03% | 13.39% | 12.21% | 11.21% | 1,229.42 | 2.15 | 0.30 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth | 8.21% | 4.38% | -0.83% | -4.8% | 4.87% | 21.77% | 13.64% | 0% | 20.1% | 2,891.76 | 1.94 | 0.31 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | 7.33% | 7.14% | -1.96% | -3.4% | 4.69% | 20.94% | 10.57% | 0% | 16.19% | 78.30 | 2.36 | 0.29 | Very High |
| ITI Pharma & Healthcare Fund - Regular Plan - Growth | 8.1% | 8.47% | -2.98% | -5.82% | 0.32% | 19.48% | 0% | 0% | 10.95% | 211.30 | 2.35 | 0.25 | Very High |
| Instrument Allocation | Instrument | Assets % |
|---|---|---|
|
|
Domestic Equities | 94.67% |
| Overseas Equities | 2.71% | |
| Cash & Cash Equivalents and Net Assets | 2.56% | |
| Treasury Bills | 0.07% |
| Sector Allocation | Sector | Assets % |
|---|---|---|
| Pharmaceuticals & Biotechnology | 64.83% | |
| Healthcare Services | 24.43% | |
| Chemicals & Petrochemicals | 5.57% | |
| Others | 2.62% | |
| Healthcare Equipment & Supplies | 2.24% | |
| Retailing | 0.30% |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 11.71% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 6.77% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.40% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 5.30% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 5.17% |
| Aster DM Healthcare Ltd. | Healthcare Services | Domestic Equities | 3.89% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.84% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.48% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.45% |
| Aether Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 3.35% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.33% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.21% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 3.20% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.12% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.06% |
| Lonza Group | Pharmaceuticals & Biotechnology | Overseas Equities | 2.71% |
| TREPS | Cash & Cash Equivalents and Net Assets | 2.68% | |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | Domestic Equities | 2.55% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.50% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.47% |
| Krishna Institute of Medical Sciences Ltd | Healthcare Services | Domestic Equities | 2.47% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.43% |
| Poly Medicure Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 2.24% |
| Sudeep Pharma Ltd. | Chemicals & Petrochemicals | Domestic Equities | 2.23% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.96% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.90% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.47% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.12% |
| Nephrocare Health Services Ltd. | Healthcare Services | Domestic Equities | 0.98% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 0.87% |
| Gufic Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.46% |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.44% |
| Medplus Health Services Ltd. | Retailing | Domestic Equities | 0.30% |
| 364 DAY T-BILL 19.11.26 | Treasury Bills | 0.07% | |
| Net Receivable / Payable | Cash & Cash Equivalents and Net Assets | -0.12% | |
| Total | 100.00% |
RETURNS
It is an Open ended scheme that primarily invests in Sector Funds.
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme benchmark is the BSE Health Care - TRI
It is classified as Very High Risk, suitable for investors with a Very High risk appetite.
Returns Delivered by the funds are as follows:
1-year: 11%
3-year: 26.68%
5-year: 16.06%
Top holdings include names such as:
The NAV is around ₹292.30 (approx.) for the SBI Healthcare Opportunities Fund - Regular Plan - IDCW.
The fund’s AUM is approximately ₹4,323 Cr.
The expense ratio for the Regular Plan is 1.9.
0.50% on or before 15D, Nil after 15D.
Minimum SIP starts at ₹1000.
The minimum lump sum investment is ₹5000. Often platforms may require higher in practice, but the statutory minimum remains the same.
You can start a SIP through:
Broker/agent platform like Sharescart.
Enter KYC details, choose the Regular Growth option, set SIP amount/frequency, and submit.
Yes. You can modify your SIP amount or frequency anytime online through the Sharescart platform.
You can redeem online via the Sharescart platform — choose the scheme, select the amount/units, and submit. Proceeds are credited to your bank account.
The fund manager: Tanmaya Desai
This fund is suitable for investors with a Very High risk tolerance.
Get personalized Portfolio Management Services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
